Freezing or adding trypsin inhibitor to equine intestinal contents extends the lifespan of Clostridium perfringens beta toxin for diagnostic purposes

Anaerobe

Volumn 18, Issue 3, 2012, Pages 357-360

  Macias Rioseco, Melissa ^a   Beingesser, Juliann ^a   Uzal, Francisco A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Beta toxin; Clostridium perfringens; ELISA; Horses; Trypsin

Indexed keywords

CLOSTRIDIUM TOXIN; TRYPSIN INHIBITOR;

ARTICLE; CLOSTRIDIUM PERFRINGENS; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZING; HORSE; INTESTINE; LD 50; LIFESPAN; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE;

ANIMALS; BACTERIAL TOXINS; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; CRYOPRESERVATION; FEMALE; GASTROINTESTINAL CONTENTS; HORSE DISEASES; HORSES; LETHAL DOSE 50; MALE; MICE; MICE, INBRED BALB C; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TRYPSIN INHIBITORS;

ANIMALIA; CLOSTRIDIUM PERFRINGENS; EQUIDAE;

EID: 84861901929     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2012.03.003     Document Type: Article

References (14)

1. Niilo L. Clostridium perfringens in animal disease: a review of current knowledge. Can Vet J 1980, 21:141-148.
2. Petit L., Gilbert M., Popoff M.R. Clostridium perfringens: toxinotype and genotype. Trends Microbol 1999, 7:104-110.
3. McClane B.A., Uzal F.A., Fernandez-Miyakawa M.E., Lyerly D.M., Wilkins T. The enterotoxigenic clostridia. The procaryotes 2006, 698-752. Springer-Verlag, New York. 3rd ed. M. Dworkin, J. Falkow (Eds.).
4. Uzal F.A., Songer J.G. Diagnosis of Clostridium perfringens intestinal infection in sheep and goats. J Vet Diagn Invest 2008, 20:253-265.
5. Matsuda T., Okada Y., Inagi E., Tanabe Y., Shimizu Y., Nagashima K., et al. Enteritis necroticans "pibgel" in a Japanese diabetic adult. Pathol Int 2007, 57:622-626.
6. Songer J.G. Clostridia enteric disease of domestic animals. Clin Microbiol Rev 1996, 9:216-234.
7. Uzal F.A., Saputo J., Sayeed S., Vidal J.E., Fisher D.J., Poon Development and application of new mouse models to study the pathogenesis of Clostridium perfringens type C enterotoxemias. Infect Immun 2009, 12:5291-5299.
8. Uzal F.A., Vidal J.E., McClane B.A. Clostridium Perfringens toxins involved in mammalian veterinary diseases. Open Toxinol J 2010, 3:24-42.
9. Diab S.S., Kinde H., Moore J., Shahriar M.F., Odani J., Anthenill L., et al. Pathology of Clostridium perfringens type C enterotoxemia in horses. Vet Path 2011, [Epub ahead of print].
10. Fisher D.J., Fernandez-Miyakawa M.E., Sayeed S., Poon R., Adams V., Rood J.I., et al. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model. Infect Immun 2006, 74:5200-5210.
11. Niilo L. Bovine enterotoxemia: III factors affecting the stability of the toxins of Clostridium perfringens types A, C and D. Can Vet J 1965, 6:38-42.
12. Oakley C.L. The toxins of Clostridium welchii: a critical review. Bull Hyg 1943, 18:781.
13. Orlans E.S., Jones V.E. Studies on some soluble antigens of Clostridium welchii types B, C and D. Immunol 1958, 1:268.
14. Bennett G.H. Diagnosis of enterotoxemia: the effect of chloroform added as a preservative to intestinal contents on test animals. Vet Rec 1961, 73:45-46.